• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

肺癌筛查资格的生物标志物检测评估。

Assessment of Biomarker Testing for Lung Cancer Screening Eligibility.

机构信息

Genetic Epidemiology Group, International Agency for Research on Cancer, Lyon, France.

Department of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway.

出版信息

JAMA Netw Open. 2020 Mar 2;3(3):e200409. doi: 10.1001/jamanetworkopen.2020.0409.

DOI:10.1001/jamanetworkopen.2020.0409
PMID:32134462
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7059020/
Abstract

This exploratory study analyzes the cost-effectiveness of incorporating biomarkers into eligibility assessment for lung screening.

摘要

本探索性研究分析了将生物标志物纳入肺癌筛查资格评估的成本效益。

相似文献

1
Assessment of Biomarker Testing for Lung Cancer Screening Eligibility.肺癌筛查资格的生物标志物检测评估。
JAMA Netw Open. 2020 Mar 2;3(3):e200409. doi: 10.1001/jamanetworkopen.2020.0409.
2
Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada.基于人群的计算机断层扫描肺癌筛查方案的性能和成本效益：加拿大安大略省的微观模拟建模分析
PLoS Med. 2017 Feb 7;14(2):e1002225. doi: 10.1371/journal.pmed.1002225. eCollection 2017 Feb.
3
Risk prediction models versus simplified selection criteria to determine eligibility for lung cancer screening: an analysis of German federal-wide survey and incidence data.风险预测模型与简化选择标准在确定肺癌筛查资格中的比较：基于德国联邦范围调查和发病数据的分析。
Eur J Epidemiol. 2020 Oct;35(10):899-912. doi: 10.1007/s10654-020-00657-w. Epub 2020 Jun 27.
4
Trade-off between benefits, harms and economic efficiency of low-dose CT lung cancer screening: a microsimulation analysis of nodule management strategies in a population-based setting.低剂量CT肺癌筛查的益处、危害与经济效率之间的权衡：基于人群的结节管理策略微观模拟分析
BMC Med. 2017 Aug 25;15(1):162. doi: 10.1186/s12916-017-0924-3.
5
Stratification and management of patients ineligible for lung cancer screening.不适合肺癌筛查患者的分层和管理。
Respir Med. 2021 Nov;188:106610. doi: 10.1016/j.rmed.2021.106610. Epub 2021 Sep 21.
6
Estimating Pack-Year Eligibility for Lung Cancer Screening Using 2 Yes or No Questions.使用两个“是”或“否”问题估计肺癌筛查的包年资格。
JAMA Netw Open. 2023 Aug 1;6(8):e2327363. doi: 10.1001/jamanetworkopen.2023.27363.
7
Cost-effectiveness of low-dose CT screening for lung cancer in a European country with high prevalence of smoking-A modelling study.在一个吸烟流行率较高的欧洲国家，低剂量 CT 筛查肺癌的成本效益：一项建模研究。
Lung Cancer. 2018 Jul;121:61-69. doi: 10.1016/j.lungcan.2018.05.008. Epub 2018 May 26.
8
Analysis shows CT lung cancer screening is cost effective.分析表明，CT肺癌筛查具有成本效益。
Cancer. 2015 Apr 1;121(7):971. doi: 10.1002/cncr.29343.
9
Age, Sex, Smoking, and Race: Is Progress Being Made in Lung Cancer Screening Eligibility?年龄、性别、吸烟与种族：肺癌筛查资格认定方面是否取得了进展？
Chest. 2021 Jul;160(1):31-33. doi: 10.1016/j.chest.2021.03.043.
10
Optimising eligibility criteria for lung cancer screening.优化肺癌筛查的入选标准。
Lancet Respir Med. 2023 Aug;11(8):665-666. doi: 10.1016/S2213-2600(23)00083-8. Epub 2023 Apr 5.

引用本文的文献

1
Protein Biomarkers in Lung Cancer Screening: Technical Considerations and Feasibility Assessment.肺癌筛查中的蛋白质生物标志物：技术考虑因素和可行性评估。
Arch Bronconeumol. 2024 Oct;60 Suppl 2:S67-S76. doi: 10.1016/j.arbres.2024.07.007. Epub 2024 Jul 17.
2
The Role of Biomarkers in Lung Cancer Screening.生物标志物在肺癌筛查中的作用。
Cancers (Basel). 2024 May 23;16(11):1980. doi: 10.3390/cancers16111980.
3
Current and Future Perspectives on Computed Tomography Screening for Lung Cancer: A Roadmap From 2023 to 2027 From the International Association for the Study of Lung Cancer.

本文引用的文献

1
Assessment of Lung Cancer Risk on the Basis of a Biomarker Panel of Circulating Proteins.基于循环蛋白生物标志物面板评估肺癌风险。
JAMA Oncol. 2018 Oct 1;4(10):e182078. doi: 10.1001/jamaoncol.2018.2078. Epub 2018 Oct 11.
2
Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening.用于选择曾经吸烟者进行CT肺癌筛查的风险模型的开发与验证
JAMA. 2016 Jun 7;315(21):2300-11. doi: 10.1001/jama.2016.6255.
3
Cost-effectiveness of CT screening in the National Lung Screening Trial.CT 筛查在全国肺癌筛查试验中的成本效益。
当前和未来视角下的肺癌计算机断层扫描筛查：2023 至 2027 年国际肺癌研究协会路线图
J Thorac Oncol. 2024 Jan;19(1):36-51. doi: 10.1016/j.jtho.2023.07.019. Epub 2023 Jul 23.
4
Liquid Biopsy for Lung Cancer: Up-to-Date and Perspectives for Screening Programs.液体活检在肺癌中的应用：筛查项目的最新进展和展望。
Int J Mol Sci. 2023 Jan 28;24(3):2505. doi: 10.3390/ijms24032505.
5
Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program.在肺癌病因和风险综合分析（INTEGRAL）计划中进行生物标志物发现和验证的设计和方法学考虑。
Ann Epidemiol. 2023 Jan;77:1-12. doi: 10.1016/j.annepidem.2022.10.014. Epub 2022 Oct 29.
6
A modeling analysis to compare eligibility strategies for lung cancer screening in Brazil.一项比较巴西肺癌筛查资格策略的建模分析。
EClinicalMedicine. 2021 Nov 1;42:101176. doi: 10.1016/j.eclinm.2021.101176. eCollection 2021 Dec.
7
A Cost-Effectiveness Analysis of Lung Cancer Screening With Low-Dose Computed Tomography and a Diagnostic Biomarker.低剂量计算机断层扫描联合诊断生物标志物用于肺癌筛查的成本效果分析。
JNCI Cancer Spectr. 2021 Oct 6;5(6). doi: 10.1093/jncics/pkab081. eCollection 2021 Dec.
8
Validation of Lung EpiCheck, a novel methylation-based blood assay, for the detection of lung cancer in European and Chinese high-risk individuals.基于甲基化的新型血液检测方法Lung EpiCheck在欧洲和中国高危个体中用于肺癌检测的验证。
Eur Respir J. 2021 Jan 14;57(1). doi: 10.1183/13993003.02682-2020. Print 2021 Jan.
N Engl J Med. 2014 Nov 6;371(19):1793-802. doi: 10.1056/NEJMoa1312547.
4
Targeting of low-dose CT screening according to the risk of lung-cancer death.根据肺癌死亡风险进行低剂量 CT 筛查的目标。
N Engl J Med. 2013 Jul 18;369(3):245-254. doi: 10.1056/NEJMoa1301851.
5
Selection criteria for lung-cancer screening.肺癌筛查的选择标准。
N Engl J Med. 2013 Feb 21;368(8):728-36. doi: 10.1056/NEJMoa1211776.
6
Reduced lung-cancer mortality with low-dose computed tomographic screening.低剂量计算机断层扫描筛查可降低肺癌死亡率。
N Engl J Med. 2011 Aug 4;365(5):395-409. doi: 10.1056/NEJMoa1102873. Epub 2011 Jun 29.